Quick Answer
ARGENX SE reported R&D Expense of $1.36 billion for fiscal year 2025.
ARGENX SE R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $1.36B | +38.7% |
| 2024 | $983.42M | +14.4% |
| 2023 | $859.49M | +29.6% |
| 2022 | $663.37M | +14.3% |
| 2021 | $580.52M | +56.5% |
| 2020 | $370.88M | +68.0% |
| 2019 | $220.77M | +164.1% |
| 2018 | $83.61M | +61.6% |
| 2017 | $51.74M | +64.0% |
| 2016 | $31.56M | +52.9% |
| 2015 | $20.64M | — |
- ARGENX SE showed an increase of +38.7% in R&D Expense compared to the prior fiscal year.
- Over the 2015–2025 period, ARGENX SE’s r&d expense has grown by 6510.8% (from $20.64 million to $1.36 billion).
- The most recent figure is from ARGENX SE’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: